HRSA audits found terminations were required for a 340B provider site and a contract pharmacy and that another provider owed repayments to drugmakers.
Two 340B Site Terminations, One Payback to Manufacturers in Latest Provider Audit Findings
Federal auditors determined terminations from the 340B program were required for either a covered entity site or a contract pharmacy [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.